EU trims exclusivity window for new drugs
Cheaper generics will be allowed on to market a year earlier to curb costs
Related reading
US set to speed up approval for some generic drugs in blow to Big Pharma
Move is latest broadside by Trump administration against pharmaceuticals industry that fought to derail changes
US to speed up payments for new medical devices
Regulators hand industry a lobbying victory after fierce effort to get faster coverage for their products
NHS to increase medicines spending to avoid threatened Trump tariffs
UK government will make it easier for drugs to be approved for use in order to secure carve-out from import levies
Markets should pay heed to the affordability squeeze
Political pressure in response to public anxiety will demand policy responses
UK urges pharma companies to invest after reaching drug pricing deal with US
Accord will result in higher medicines spending in Britain in exchange for exemption from threatened Trump tariffs
Short rates have overshot
Plus the social media lawsuits